nagashima ryuichi 長島隆一

… Alternative Names

長島隆一ナガシマリュウイチ

Nagashima Ryuichi 長島隆一

Less

Researcher Number	20783707
Other IDs
Affiliation (Current)	2023: 昭和大学, 医学部, 助教
Affiliation (based on the past Project Information) *help	2022: 昭和大学, 医学部, 助教 2016 – 2020: 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 研究技師
Review Section/Research Field	Principal Investigator Pediatrics / Basic Section 52050:Embryonic medicine and pediatrics-related / Basic Section 53040:Nephrology-related Except Principal Investigator Respiratory organ internal medicine / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator ILC2 / Nrf2 / アレルギー / 酸化ストレス / Keap1-Nrf2 / 免疫学 / アレルギー・ぜんそく / ILC3 / IBD / 腎線維化 / CKD … More Except Principal Investigator … More 癌 / 非小細胞肺がん / 好中球 / 非小細胞肺癌 / 肺癌 / EGFR / 抗腫瘍免疫 / がん / 細胞骨格 / 癌幹細胞 / 造腫瘍性 / 微小環境 / 分子標的治療 / 幹細胞 / がん微小環境 / 細胞接着運動 Less

2型自然リンパ球に着目した慢性腎臓病の分子病態解明と治療応用Principal Investigator
- Principal Investigator
  
  長島隆一
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Showa University
Elucidation of pediatric IBD control mechanism by Keap1-Nrf2 system and innate lymphoid cells and development to treatmentPrincipal Investigator
- Principal Investigator
  
  Nagashima Ryuichi
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 52050:Embryonic medicine and pediatrics-related
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
S100A10 on Cancer Stem Cell and Microenvironment: Towards therapeutic application
- Principal Investigator
  
  TANAKA NOBUYUKI
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
Keap1-NRF2 system is a potential therapeutic strategy to regulate pediatric allergic disease.Principal Investigator
- Principal Investigator
  
  Nagashima Ryuichi
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pediatrics
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center
Tumor associated Neutrophils control NSCLC-Immune interface
- Principal Investigator
  
  FUKUHARA TATSURO
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Miyagi Prefectural Hospital Organization Miyagi Cancer Center

All 2021 2019 2018 2017

All Journal Article Presentation

[Journal Article] Efficient immunogenic peptide antigen delivery to dendritic cells using an ESCRT-mediated extracellular vesicle formation method2021
- Author(s)
  Sakika Kimura 1 , Koki Maeda, Ryuichi Nagashima, Koya Miura, , Masashi Arakawa, Hirotaka Ebina, Nobuyuki Tanaka , Eiji Morita.
- Journal Title
  
  Vaccine
  
  Volume: 39 Pages: 2976-2982
- DOI
  10.1016/j.vaccine.2021.04.021
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02701, KAKENHI-PROJECT-20K21874, KAKENHI-PUBLICLY-20H05305
[Journal Article] Nrf2 Suppresses Allergic Lung Inflammation by Attenuating the Type 2 Innate Lymphoid Cell Response2019
- Author(s)
  Nagashima Ryuichi、Kosai Hitomi、Masuo Masahiro、Izumiyama Keiko、Noshikawaji Taketo、Morimoto Motoko、Kumaki Satoru、Miyazaki Yasunari、Motohashi Hozumi、Yamamoto Masayuki、Tanaka Nobuyuki
- Journal Title
  
  The Journal of Immunology
  
  Volume: 202 Pages: 1331-1339
- DOI
  10.4049/jimmunol.1801180
- NAID
  40022064970
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K19417, KAKENHI-PLANNED-26111002, KAKENHI-PROJECT-17F17116, KAKENHI-PROJECT-16K09576, KAKENHI-PROJECT-17K19508, KAKENHI-PROJECT-17K16287, KAKENHI-PUBLICLY-18H04794, KAKENHI-PROJECT-18H02621
[Presentation] Keap1-Nrf2 system regulates ILC3 function and plasticity in intestinal inflammation.2019
- Author(s)
  Ryuichi Nagashima
- Organizer
  第48回日本免疫学会
- Data Source
  KAKENHI-PROJECT-19K17348
[Presentation] Nrf2 suppresses allergic lung inflammation by attenuating the type2-innate lymphoid cell response.2018
- Author(s)
  Ryuichi Nagashima, Hitomi Kosai, Keiko Izumiyama, Nobuyuki Tanaka.
- Organizer
  The 3rd international conference on innate lymphoid cells (ILC2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16287
[Presentation] Nrf2 activation suppressed lung allergic inflammation induced by type2-innate lymphoid cells.2017
- Author(s)
  Ryuichi Nagashima, Hozumi Motohashi, Nobuyuki Tanaka
- Organizer
  第46回日本免疫学会
- Data Source
  KAKENHI-PROJECT-17K16287
[Presentation] Nrf2活性化による2型自然リンパ球（ILC2）抑制現象の発見とステロイド抵抗性アレルギーに対する新規治療法への展開2017
- Author(s)
  長島隆一, 小斎仁美, 田中伸幸
- Organizer
  第71回細菌学会東北支部総会
- Data Source
  KAKENHI-PROJECT-17K16287

1. TANAKA NOBUYUKI (60280872)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
2. FUKUHARA TATSURO (80400365)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 前門戸任 (40344676)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 森田英嗣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 山本雅之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. 本橋ほづみ

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 宮崎泰成

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

nagashima ryuichi 長島 隆一

長島 隆一 ナガシマ リュウイチ

Nagashima Ryuichi 長島 隆一

Research Projects

Research Products

Co-Researchers

2型自然リンパ球に着目した慢性腎臓病の分子病態解明と治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of pediatric IBD control mechanism by Keap1-Nrf2 system and innate lymphoid cells and development to treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

S100A10 on Cancer Stem Cell and Microenvironment: Towards therapeutic application

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Keap1-NRF2 system is a potential therapeutic strategy to regulate pediatric allergic disease.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Tumor associated Neutrophils control NSCLC-Immune interface

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Efficient immunogenic peptide antigen delivery to dendritic cells using an ESCRT-mediated extracellular vesicle formation method2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nrf2 Suppresses Allergic Lung Inflammation by Attenuating the Type 2 Innate Lymphoid Cell Response2019

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Keap1-Nrf2 system regulates ILC3 function and plasticity in intestinal inflammation.2019

Author(s)

Organizer

Data Source

[Presentation] Nrf2 suppresses allergic lung inflammation by attenuating the type2-innate lymphoid cell response.2018

Author(s)

Organizer

Data Source

[Presentation] Nrf2 activation suppressed lung allergic inflammation induced by type2-innate lymphoid cells.2017

Author(s)

Organizer

Data Source

[Presentation] Nrf2活性化による2型自然リンパ球（ILC2）抑制現象の発見とステロイド抵抗性アレルギーに対する新規治療法への展開2017

Author(s)

Organizer

Data Source

nagashima ryuichi 長島隆一

長島隆一ナガシマリュウイチ

Nagashima Ryuichi 長島隆一